The TME’s role extends to modulating immune surveillance, where dormant lung cancer cells evade immune-mediated clearance by upregulating Immune Checkpoint Inhibitors (ICI) such as PD-L1 and downregulating antigen presentation machinery, creating an immunosuppressive niche [98]. Here, CD274 is linked to lung cancer.